Frontier Medicines

A couple of important gems from the (over-crowded) poster halls really stood out for me this year at #AACR24. Will have some important clinical implications should the concept hold up in patients: bit.ly/49AXKGn

The Frontier Medicines team wishes everyone in the U.S. a happy and healthy #July4th!

Our science never stops, but today our offices are closed, as we recognize the importance of #Juneteenth. #listeningandlearning

Are you at #BIO2023? Will the IPO market return? Join our CEO, Chris Varma, and leading experts in the field, as they discuss the current biotech financial climate. This afternoon at 2:15 p.m. ET Room 210A #standupforscience

This month, and every month, we honor and celebrate the LGBTQIA+ community. #PrideMonth #Pride2023

We are thrilled to welcome Dr. Andrew Krivoshik as CMO. He has advanced multiple groundbreaking medicines, and we’re excited to have him join Frontier as we prepare to move FMC-376 into the clinic. Read more here bitly.ws/EbVk #biotech, #chemoproteomics

Decades after the human genome project, only 15% of the human proteome has approved treatments. We’re opening up new Frontiers in what is possible. Learn more here: frontiermeds.com/science-platfo… #DNADay #DNADay23 #biotech #chemoproteomics

Today at #AACR23, we’re talking about the Frontier™ platform, which gives us the tools to open new frontiers in drugging the undruggable. Visit poster 5333 (Section 30, Board 15). Learn more here: frontiermeds.com/science-platfo…

Thanks @MaverickNY, we’re feeling the AACR sunshine here at Frontier.

We’re excited to unveil new preclinical data on our lead candidate, FMC-376, at #AACR23 More here: bit.ly/3mAEJRX

We are excited to join the oncology community this week at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #cancer

We are excited to join our colleagues in #biotech at #AACR23 in Orlando as we present updates on our lead candidate and the Frontier™ Platform. #oncology #chemoproteomics #undruggable rb.gy/hnkzbn

Please join us in welcoming Christo as Frontier’s SVP and Head of Business Development! His global pharma background coupled with his leadership experience in growing biotechs will be invaluable as we continue on our rapid trajectory. bit.ly/welcomechristo #biotech

At 12, Kyle knew she wanted to be a scientist. Now, she is helping to discover new breakthroughs for patients. We are proud to support scientists, especially the #WomeninScience here at Frontier. Tomorrow is International Day of Women & Girls in Science! #February11 #Biotech

Kainat vividly recalls being the only girl at 4th grade math camp and advanced computing classes. Luckily for our Frontier™ Platform team, that only fueled her passion for STEM. This #February11, we applaud Kainat and all the #WomeninScience at Frontier and everywhere. #Biotech

Our executive team is hosting meetings at the SVB Global Biopharma Conference. We hope to (virtually) see you there!

Thanks @ldtimmerman for braving the floods and the hail to speak with our CEO, Chris Varma. The things we do for science! #JPM23

We’re excited to finally reconvene in person for this week’s 41st Annual @jpmorgan Health Care Conference. If you are here, please join our CEO, Chris Varma, for his presentation. January 11, 2023, 10:00 a.m. PST #JPM23 #Biotech

We are excited to welcome Dr. Pamela Klein to our board of directors. Dr. Klein is a medical oncologist and senior biotechnology executive with over 20 years of experience who has advanced important cancer therapies to patients. #boardofdirectors